Trials in Delaware.
6 APOE4-relevant Alzheimer’s trials run in Delaware — 1 of them recruiting. Each one translated into plain English, with our read on what it means for an APOE4 carrier.
- Non-carriers only, not for APOE4NCT00574132Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
This trial tested bapineuzumab, an infused antibody designed to bind and clear beta amyloid from the brain, against a placebo. It measured whether it helped…
- Drug trial for diagnosed APOE4 carriersNCT00575055Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
This trial tested whether bapineuzumab, an antibody given by infusion that helps clear beta amyloid from the brain, could affect thinking and daily function in…
- APOE4 carriers explicitly excludedNCT07612449Percepta for Cognitive Optimization
This trial is testing a dietary supplement called Percepta, made from cat's claw bark extract and oolong tea extract, to see whether it improves cognitive…
- Cancer trial, not for healthy carriersNCT01227954Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
This trial tests whether a more precise form of whole-brain radiation can spare the hippocampus, the brain's memory center, in people whose cancer has spread…
- Open to carriers, not 4-specificNCT04820335Promoting Independence With Compensatory Cognitive Rehabilitation
This trial is testing a behavioral training program called SEMAT, which teaches people with mild cognitive impairment practical memory strategies and external…
- Observational only, genotype not consideredNCT06493422Online Interplay Between Deciding and Acting With Mild Cognitive Impairment
This study is watching how people with mild cognitive impairment make decisions and move their arms at the same time — specifically how quickly the brain…
Copy a forum-ready post
Keep exploring
Educational, not medical advice. Trial decisions belong between you and your physician.